Developing a SMART scaffold for bladder augmentation

开发用于膀胱扩张的 SMART 支架

• 批准号: 10429930
• 负责人: Guillermo Antonio Ameer
• 金额: $ 68.14万
• 依托单位: NORTHWESTERN UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-08-09 至 2024-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10429930
• 关键词: Acute Kidney Failure; Anatomy; Animal Model; Antioxidants; Autologous; Biocompatible Materials; Biologic Characteristic; Bladder; Bladder Control; Bladder Tissue; Blood Vessels; CD34 gene; Catheterization; Cells; Citrates; Clinical; Clinical Research; Data; Development; Disease; Elasticity; Elastomers; Electronics; Engineering; Extravasation; Failure; Functional Regeneration; Glycolates; Goals; Hematopoietic stem cells; Heterogeneity; Human; Inflammatory; Interstitial Cystitis; Intestines; Kidney Failure; Life; Light; Malignant - descriptor; Measures; Mesenchymal Stem Cells; Modeling; Monitor; Natural regeneration; Operative Surgical Procedures; Outcome; Papio; Pathologic; Patient Care; Patient-Focused Outcomes; Patients; Perforation; Performance; Phylogenetic Analysis; Physics; Physiological; Polymers; Predisposition; Problem Solving; Process; Radiation therapy; Rattus; Regenerative engineering; Reporting; Safety; Science; Scientist; Serious Adverse Event; Small Intestinal Submucosa; Spinal Dysraphism; Stretching; System; Technology; Telemetry; Time; Tissues; Trauma; United States; Urine; Urologic Cancer; Work; base; biocompatible scaffold; biomaterial compatibility; bone marrow mesenchymal stem cell; canine model; clinical translation; clinically relevant; design; experimental study; improved; in vivo; innovation; materials science; mechanical properties; optogenetics; outcome prediction; poly(lactic acid); pre-clinical; pressure; reconstruction; regeneration function; regenerative; scaffold; scale up; standard of care; stem cells; surgery outcome; tissue regeneration; tool; wireless electronic; wireless transmission

SUMMARY Each year in the United States, trauma, radiation therapy to treat urological cancers, severe cases of spina bifida, and interstitial cystitis contribute to at least 14,000 bladder augmentation enterocystoplasty surgeries. Although it is the standard of care for patients with an end-stage pathologic bladder, enterocystoplasty causes many complications due to anatomical and physiological differences between bladder tissue and the bowel tissue used to augment the bladder’s capacity. Several strategies have been reported to replace enterocystoplasty and regenerate bladder tissue but these have failed clinically. Reasons for the failure include the common use of phylogenetically dissimilar pre-clinical animal models that do not accurately represent the human bladder or its disease condition, the use of inadequate materials to serve as scaffolds for cells to grow on and regenerate bladder tissue, the use of often diseased autologous bladder cells that have lost the capacity to regenerate functional bladder tissue, and an inability to continuously monitor the tissue regeneration process to identify potential problems at an early stage. As a result, there is currently no viable alternative to augmentation enterocystoplasty. Regenerative engineering is a convergence of advanced material science, stem cell science, physics, and clinical translation. The overall goal of this project is to drive the development of unprecedented regenerative engineering tools and technologies via the integration of stem cell science, advanced biomaterials, and bio-integrated electronics to enable the regeneration of functional bladder tissue and the non-invasive, real-time assessment thereof to better predict outcome. Toward this goal, we have demonstrated our ability to: a) regenerate vascularized and innervated bladder tissue in a rat bladder augmentation model using a combination of bone marrow (BM) mesenchymal stem cells (MSCs), hematopoietic stem/progenitor cells (HSPCs), and an antioxidant citrate-based biodegradable elastomer, b) demonstrated successful bladder reconstruction with autologous cell-seeded POC scaffolds at 6 months in baboon; c) measure rat bladder pressure and control its function via a bio-integrated electronic strain gauge and light-activated excitatory channels, d) integrate stretchable electronics into citrate-based elastomers, and e) achieve wireless transmission of real time physiological data obtained in vivo using bio-integrated electronics. Towards our goal, the specific aims of this proposal are to: 1) Design, fabricate, and characterize bio-integrated electronics that monitor and modulate the function of regenerating bladder tissue via telemetry, 2) Engineer and characterize Stretch Monitoring Advanced Regenerative Telemetric (SMART) scaffolds for bladder augmentation, and 3) Assess the safety and efficacy of bladder conformal stretchable electronics and SMART scaffolds in a baboon bladder augmentation model.

总结 每年在美国，创伤，放射治疗，以治疗泌尿系统癌症，严重的情况下，脊柱 裂和间质性膀胱炎导致至少14，000例膀胱扩大肠膀胱成形术。 虽然它是治疗终末期病理性膀胱患者的标准，但肠膀胱成形术会导致 由于膀胱组织和肠之间的解剖学和生理学差异导致的许多并发症 用来增加膀胱容量的组织。据报道，有几种策略可以取代 肠膀胱成形术和再生膀胱组织，但这些在临床上都失败了。失败的原因包括 通常使用遗传学上不同的临床前动物模型，这些模型不能准确代表 人类膀胱或其疾病状况，使用不适当的材料作为细胞生长的支架 在膀胱组织上和再生膀胱组织，使用经常患病的自体膀胱细胞， 再生功能性膀胱组织的能力，以及不能持续监测组织 再生过程，以确定在早期阶段的潜在问题。因此，目前没有可行的 肠膀胱扩大术的替代方法。再生工程是一种先进的 材料科学、干细胞科学、物理学和临床翻译。该项目的总体目标是推动 前所未有的再生工程工具和技术的发展，通过集成干 细胞科学，先进的生物材料和生物集成电子学，使功能的再生 膀胱组织和其非侵入性实时评估，以更好地预测结果。为了实现这一目标， 我们已经证明了我们的能力：a）在大鼠膀胱中再生血管化和神经支配的膀胱组织 使用骨髓（BM）间充质干细胞（MSC）， 造血干/祖细胞（HSPC）和抗氧化剂柠檬酸盐基生物可降解弹性体，B） 在6个月时，证明了用自体细胞接种的POC支架成功地进行了膀胱重建。 狒狒; c）通过生物集成电子应变计测量大鼠膀胱压力并控制其功能 d）将可拉伸电子器件集成到基于柠檬酸盐的弹性体中，以及 e）实现使用生物集成技术在体内获得的真实的时间生理数据的无线传输 electronics.为了实现我们的目标，本提案的具体目标是：1）设计，制造和表征 通过遥测监测和调节再生膀胱组织功能的生物集成电子器件， 2)设计和表征拉伸监测高级再生遥测（SMART）支架， 膀胱扩张，以及3）评估膀胱适形可拉伸电子器件的安全性和有效性， 狒狒膀胱增大模型中的SMART支架。